期刊
CELL CYCLE
卷 13, 期 24, 页码 3878-3891出版社
TAYLOR & FRANCIS INC
DOI: 10.4161/15384101.2014.972889
关键词
ChIP; HIF; Histone methylation; HIF-1; hypoxia; JMJC; JMJD2B; PITX1; transcription
类别
资金
- Cancer Research UK [C99667/A12918]
- Cancer Research UK
- Portuguese Science Foundation
- GABBA PhD program
- MRC-PhD studentship
- Tenovus Scotland small grant
- Wellcome Trust strategic award [097945/Z/11/Z]
- Wellcome Trust [097945/Z/11/Z] Funding Source: Wellcome Trust
- Cancer Research UK [12918] Funding Source: researchfish
- Medical Research Council [1517494, 1101605] Funding Source: researchfish
Hypoxia is an important developmental cue for multicellular organisms but it is also a contributing factor for several human pathologies, such as stroke, cardiovascular diseases and cancer. In cells, hypoxia activates a major transcriptional program coordinated by the Hypoxia Inducible Factor (HIF) family. HIF can activate more than one hundred targets but not all of them are activated at the same time, and there is considerable cell type variability. In this report we identified the paired-like homeodomain pituitary transcription factor (PITX1), as a transcription factor that helps promote specificity in HIF-1 dependent target gene activation. Mechanistically, PITX1 associates with HIF-1 and it is important for the induction of certain HIF-1 dependent genes but not all. In particular, PITX1 controls the HIF-1-dependent expression of the histone demethylases; JMJD2B, JMJD2A, JMJD2C and JMJD1B. Functionally, PITX1 is required for the survival and proliferation responses in hypoxia, as PITX1 depleted cells have higher levels of apoptotic markers and reduced proliferation. Overall, our study identified PITX1 as a key specificity factor in HIF-1 dependent responses, suggesting PITX1 as a protein to target in hypoxic cancers.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据